NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Economics, Pharmaceutical Remove constraint Subjects: Economics, Pharmaceutical Subjects Humans Remove constraint Subjects: Humans Publication Year 2000 to 2024 Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

Search Results

2. Snapshots of recent state initiatives in Medicaid prescription drug cost control

3. Prior authorization requirements for proprotein convertase subtilisin/kexin type 9 inhibitors across US private and public payers

4. Indication-specific pricing of pharmaceuticals in the United States health care system: a report from the 2015 ICER Membership Policy Summit

5. The prescription drug safety net: access to pharmaceuticals for the uninsured

6. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

8. The effect of Medicare Part D on evergreening, generic entry, and drug prices

10. Cost savings